StockData
Lifevantage Corp logo

Lifevantage Corp (LFVN) stock

LFVNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 20/3043% below fair value
$4.81+0.03 (+0.63%)

Close on Nov 18, 2026Market cap $60.26MP/E 12.0Yield 3.85%

Lifevantage free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Lifevantage's free cash flow for the twelve months ending Jun 30, 2026 was $6.67M, down 36.5% year over year. For fiscal 2026 it was $6.67M, down 36.5% from the year before. Over ten years it grew 2.0% a year on average. The highest annual figure on record is $17.20M in fiscal 2012.

Annual free cash flow

PeriodPeriod endValueChange
FY2026Jun 30, 2026$6.67M-36.5%
FY2025Jun 30, 2025$10.51M+5.6%
FY2024Jun 30, 2024$9.95M+164.6%
FY2023Jun 30, 2023$3.76M-41.5%
FY2022Jun 30, 2022$6.43M-48.7%
FY2021Jun 30, 2021$12.53M-19.9%
FY2020Jun 30, 2020$15.65M+2.4%
FY2019Jun 30, 2019$15.28M+77.6%
FY2018Jun 30, 2018$8.61M+55.3%
FY2017Jun 30, 2017$5.54M+1.2%
FY2016Jun 30, 2016$5.47M-54.6%
FY2015Jun 30, 2015$12.06M+18.2%
FY2014Jun 30, 2014$10.21M+82.9%
FY2013Jun 30, 2013$5.58M-67.5%
FY2012Jun 30, 2012$17.20M+277.2%
FY2011Jun 30, 2011$4.56M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2026CQ2 2026Jun 30, 2026$3.73M+346.7%
Q3 FY2026CQ1 2026Mar 31, 2026$3.98M+109.6%
Q2 FY2026CQ4 2025Dec 31, 2025$1.71M-80.4%
Q1 FY2026CQ3 2025Sep 30, 2025-$2.74M–
Q4 FY2025CQ2 2025Jun 30, 2025$835.00K-63.8%
Q3 FY2025CQ1 2025Mar 31, 2025$1.90M-32.3%
Q2 FY2025CQ4 2024Dec 31, 2024$8.71M+617.2%
Q1 FY2025CQ3 2024Sep 30, 2024-$932.00K-125.7%
Q4 FY2024CQ2 2024Jun 30, 2024$2.30M-29.1%
Q3 FY2024CQ1 2024Mar 31, 2024$2.80M+14.2%
Q2 FY2024CQ4 2023Dec 31, 2023$1.21M+833.8%
Q1 FY2024CQ3 2023Sep 30, 2023$3.63M–
Q4 FY2023CQ2 2023Jun 30, 2023$3.25M+29.3%
Q3 FY2023CQ1 2023Mar 31, 2023$2.45M+701.6%
Q2 FY2023CQ4 2022Dec 31, 2022$130.00K-96.3%
Q1 FY2023CQ3 2022Sep 30, 2022-$2.07M-2481.6%
Q4 FY2022CQ2 2022Jun 30, 2022$2.51M-68.2%
Q3 FY2022CQ1 2022Mar 31, 2022$306.00K-77.0%
Q2 FY2022CQ4 2021Dec 31, 2021$3.52M-33.8%
Q1 FY2022CQ3 2021Sep 30, 2021$87.00K–
Q4 FY2021CQ2 2021Jun 30, 2021$7.89M-10.0%
Q3 FY2021CQ1 2021Mar 31, 2021$1.33M-51.4%
Q2 FY2021CQ4 2020Dec 31, 2020$5.32M-36.2%
Q1 FY2021CQ3 2020Sep 30, 2020-$2.01M–
Q4 FY2020CQ2 2020Jun 30, 2020$8.78M+42.3%
Q3 FY2020CQ1 2020Mar 31, 2020$2.74M+11.9%
Q2 FY2020CQ4 2019Dec 31, 2019$8.34M+90.1%
Q1 FY2020CQ3 2019Sep 30, 2019-$4.21M-284.7%
Q4 FY2019CQ2 2019Jun 30, 2019$6.17M+47.2%
Q3 FY2019CQ1 2019Mar 31, 2019$2.45M+32.0%
Q2 FY2019CQ4 2018Dec 31, 2018$4.39M+254.6%
Q1 FY2019CQ3 2018Sep 30, 2018$2.28M+71.8%
Q4 FY2018CQ2 2018Jun 30, 2018$4.19M+202.5%
Q3 FY2018CQ1 2018Mar 31, 2018$1.85M–
Q2 FY2018CQ4 2017Dec 31, 2017$1.24M-40.4%
Q1 FY2018CQ3 2017Sep 30, 2017$1.33M-52.4%
Q4 FY2017CQ2 2017Jun 30, 2017$1.39M–
Q3 FY2017CQ1 2017Mar 31, 2017-$706.00K–
Q2 FY2017CQ4 2016Dec 31, 2016$2.08M–
Q1 FY2017CQ3 2016Sep 30, 2016$2.79M–

More Lifevantage figures

See a number that looks wrong?